Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2014
Title: Ivan Kanizsai: Innovator in Pharmaceutical Compounds
Introduction
Ivan Kanizsai is a notable inventor based in Szeged, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on compounds that have potential medical applications.
Latest Patents
Ivan Kanizsai holds a patent for 8-hydroxy-quinoline derivatives. This invention relates to compounds of the general formula (I) and their pharmaceutically acceptable salts. In this formula, R represents a hydrogen atom, lower alkyl group, lower alkenyl group, lower cycloalkyl group, aryl group, aralkyl group, or heterocyclic group. These groups can be optionally substituted in ortho, meta, and/or para positions with 1, 2, 3, or 4 electron-withdrawing or electron-donating groups. The compounds according to this invention can be used in medicine, mainly for the treatment of diseases associated with neurological and/or oxidative stress. He has 1 patent to his name.
Career Highlights
Throughout his career, Ivan Kanizsai has worked with several companies, including Avidin Kutato, Fejleszto Es Kereskedelmi Korlatolt Felelossegu Tarsasag and Ubichem Kutato Korlatolt Felelossegu Tarsasag. His work in these organizations has contributed to advancements in research and development in the pharmaceutical sector.
Collaborations
Ivan has collaborated with notable individuals in his field, including Laszlo Puskas and Csaba Szabo. These partnerships have likely enhanced his research and innovation efforts.
Conclusion
Ivan Kanizsai is a distinguished inventor whose work on 8-hydroxy-quinoline derivatives showcases his commitment to advancing medical science. His contributions are significant in the realm of pharmaceuticals, and his collaborations further enhance the impact of his innovations.